2Cooper DS, Goldminz D, Levin AA, et al. Agranuloeytosis &ssoeiated with antithyroid drugs[J] .Ann Inter Med, 1983, 98:26-29.
3Tamai H, Sudo T, Kimura A, et al.Association between the DRB1 * 08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease [J]. Ann Intern Med 1996, 124(5) :490-494.
4[1]Klastersky J,Paesmans M,Rubenstein E J,et al.The Multinational Association for Supportive Care in Cancer Risk Index:A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients.J Clin Oncol,2000,18 (16):3038-51.
5[2]Talcott JA,Finberg R,Mayer RJ,Goldman L.The medical course of cancer patients with fever and neutropenia.Arch Intern Med,1988,148:2561-68.
7Hughes WT,Armstrong D,Bodey GP,et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J]. Clin Infect Dis,2002,15:34(6) :730 -751.
8Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[ J ]. N Engl J Med,2002,347(6) :408 -415.
9Castagnola E, Machetti M, Cappelli B, et al. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant [ J]. Clin Microbiol Infect,2004,10(3) :255 -257.
10Landman D, Mobarakai NK, Quale JM. Novel antibiotic regimens against Enterococcus faecinm resistant to ampicillin, vancomycin, and gentamicin. Antimicrob [ J ]. Agents Chemother, 1993,37 (9) : 1904 - 1908.
